Ifosfamide/carboplatin/etoposide/paclitaxel in advanced lung cancer: Update and preliminary survival analysis

Seminars in Oncology

Volumn 24, Issue 4 SUPPL.12, 1997, Pages

  Strauss, G M ^a   Lynch, T J ^a   Elias, A D ^a   Jacobs, C ^a   Herbst, R ^a   Leong, T ^a   Lynch, C ^a   Kwiatkowski, D J ^a   Carey, R W ^a   Grossbard, M L ^a   Skarin, A T ^a  

^a DANA FARBER CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOPLATIN; ETOPOSIDE; GRANULOCYTE COLONY STIMULATING FACTOR; IFOSFAMIDE; PACLITAXEL;

ADULT; ADVANCED CANCER; AGED; BLOOD TOXICITY; CANCER SURVIVAL; CARDIOTOXICITY; CLINICAL ARTICLE; CLINICAL TRIAL; CONFERENCE PAPER; DOSE RESPONSE; DRUG HYPERSENSITIVITY; DRUG RESPONSE; FATIGUE; FEMALE; GASTROINTESTINAL TOXICITY; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LIVER TOXICITY; LUNG CANCER; MALE; NEUROTOXICITY; PRIORITY JOURNAL; SUBCUTANEOUS DRUG ADMINISTRATION;

EID: 0030800728     PISSN: 00937754     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (33)